Experiment 201940

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SERRATIA ANTIBIOTIC FR-177391

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
LIPOPROTEIN LIPASE STIMULATION
OrganismSerratia liquifaciens (ENTEROBACTERIACEAE)
CitationSATO,BJ: ITO,K: FUJITA,T: TAKASE,S: TERANO,H:. (1996). ANTITUMORIC SUBSTANCE FR177391 MANUFACTURE WITH SERRATIA.. ()
Amount utilized
Compound isolated
Number3
Qualitative resultACTIVE
Dose expressionCONC USED